Heterocyclic compounds for use in the treatment of disorders of the urinary tract

Details for Australian Patent Application No. 2002346979 (hide)

Owner Recordati S.A.

Inventors Riva, Carlo; Motta, Gianni; Testa, Rodolfo; Leonardi, Amedeo; Corbett, Jeff W

Agent FB Rice

Pub. Number AU-B-2002346979

PCT Number PCT/EP02/11282

PCT Pub. Number WO2003/031436

Priority MI2001A002060 05.10.01 IT

Filing date 7 October 2002

Wipo publication date 22 April 2003

Acceptance publication date 29 September 2005

International Classifications

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 215/12 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/08 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 215/40 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 031/47 - Quinolines

C07D 215/18 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 409/08 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 215/42 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/26 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 031/404

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 215/20 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61P 013/00 Drugs for disorders of the urinary system

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): MI2001A002060 05.10.01 IT

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002346979

3 June 2004 Amendment Made

  The nature of the amendment is: Delete the applicant Recordati Industria Chimica e Farmaceutica S.p.A.

29 September 2005 Application Accepted

  Published as AU-B-2002346979

2 February 2006 Standard Patent Sealed

7 December 2006 Assignment Registered

  Recordati S.A. The patent has been assigned to Recordati Ireland Limited

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346980-ELEKTRISCHE SCHALTEINRICHTUNG SOWIE VERWENDUNG

2002346978-REGULATION OF HUMAN GTPASE